Resultado da Busca
21 de fev. de 2021 · Brain metastases (BM) from colorectal cancer (CRC) are rare. There is little available information regarding incidence, risk factors, prognostic factors, treatment, and overall survival (OS). In this systematic review we performed a research of the current literature and exposed an average incidence of 2.10%.
- Brain metastasis from colorectal cancer: Treatment, survival ...
To investigate the clinical characteristics, survival,...
- Brain metastasis from colorectal cancer: Treatment, survival ...
Brain Metastases from Colorectal Cancer: Risk Factors, Incidence, and the Possible Role of Chemokines. John P. Mongan,1,2 Camilo E. Fadul,3 Bernard F. Cole,4 Bassem I. Zaki,5 Arief A. Suriawinata,6 Gregory H. Ripple,3 Tor D. Tosteson,7 J. Marc Pipas2,3. Abstract. Background: Brain metastases from colorectal cancer (CRC) are uncommon.
4 de fev. de 2020 · Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population. Methods: 104 patients with brain metastasis disease from CRC were identified from over 30,000 colorectal cancer patients at the Mayo Clinic ...
- Zhaohui Jin, William Breen, Rui Jin, Paul D. Brown, Joleen Marie Hubbard
- 2020
22 de jan. de 2021 · In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metastases. Methods: We identified stage 4 colorectal adenocarcinoma patients with brain metastasis using the National Cancer Database diagnosed between 2010 and 2015.
- Suleyman Yasin Goksu, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Emrah Gumusgoz, David Hsieh, Muhamm...
- 2021
Brain metastases (BM) from colorectal cancer (CRC) are a rare event. However, the implications for affected patients are severe, and the incidence has been reported to be increasing. For clinicians, knowledge about the characteristics associated with BM is important and could lead to earlier diagnosis and improved survival. Method:
Although brain metastases from colorectal cancer are unusual, an increase in incidence has been observed. Previous studies evaluating this population are old and have small sample sizes, but systemic therapy has improved.
